5 Health Services Stocks Driving The Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 14 points (0.1%) at 14,951 as of Friday, Sept. 6, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,968 issues advancing vs. 907 declining with 132 unchanged.

The Health Services industry currently sits up 0.1% versus the S&P 500, which is up 0.2%. Top gainers within the industry include HCA Holdings ( HCA), up 2.3%, Grifols ( GRFS), up 1.5%, C.R. Bard ( BCR), up 0.9%, Express Scripts ( ESRX), up 0.9% and Zimmer Holdings ( ZMH), up 0.6%. A company within the industry that fell today was Emeritus Corporation ( ESC), up 8.6%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Stryker Corporation ( SYK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Stryker Corporation is up $1.52 (2.2%) to $69.31 on heavy volume. Thus far, 1.1 million shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $68.06-$70.38 after having opened the day at $69.88 as compared to the previous trading day's close of $67.79.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. Stryker Corporation has a market cap of $25.4 billion and is part of the health care sector. Shares are up 23.7% year to date as of the close of trading on Thursday. Currently there are 14 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 12 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Becton Dickinson ( BDX) is up $0.47 (0.5%) to $99.29 on light volume. Thus far, 261,589 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 874,100 shares. The stock has ranged in price between $97.94-$99.67 after having opened the day at $98.83 as compared to the previous trading day's close of $98.82.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $19.2 billion and is part of the health care sector. Shares are up 26.4% year to date as of the close of trading on Thursday. Currently there are 4 analysts that rate Becton Dickinson a buy, 4 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Becton Dickinson Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, St Jude Medical ( STJ) is up $1.64 (3.2%) to $52.60 on heavy volume. Thus far, 1.7 million shares of St Jude Medical exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $51.27-$52.67 after having opened the day at $51.27 as compared to the previous trading day's close of $50.96.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $14.6 billion and is part of the health care sector. Shares are up 41.0% year to date as of the close of trading on Thursday. Currently there are 11 analysts that rate St Jude Medical a buy, 2 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full St Jude Medical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Baxter International ( BAX) is up $0.37 (0.5%) to $70.15 on average volume. Thus far, 1.1 million shares of Baxter International exchanged hands as compared to its average daily volume of 2.7 million shares. The stock has ranged in price between $69.53-$70.35 after having opened the day at $70.02 as compared to the previous trading day's close of $69.78.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $37.8 billion and is part of the health care sector. Shares are up 4.7% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Baxter International a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is up $0.35 (0.5%) to $74.39 on light volume. Thus far, 1.5 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 4.5 million shares. The stock has ranged in price between $72.55-$74.53 after having opened the day at $74.21 as compared to the previous trading day's close of $74.04.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $74.6 billion and is part of the health care sector. Shares are up 36.5% year to date as of the close of trading on Thursday. Currently there are 15 analysts that rate UnitedHealth Group a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full UnitedHealth Group Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Sohn Conference Briefly Distracts From Barrage of Earnings -- ICYMI

Sohn Conference Briefly Distracts From Barrage of Earnings -- ICYMI

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Video: Stop Using Student Loan Money to Buy Bitcoin

Video: Stop Using Student Loan Money to Buy Bitcoin

Let the Najarian Brothers Crash-Proof Portfolio

Let the Najarian Brothers Crash-Proof Portfolio

Facebook Sends Facial Recognition Notification in Error

Facebook Sends Facial Recognition Notification in Error